<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04076904</url>
  </required_header>
  <id_info>
    <org_study_id>cesarean niche</org_study_id>
    <nct_id>NCT04076904</nct_id>
  </id_info>
  <brief_title>Cesarean Niche Examination by Transvaginal us</brief_title>
  <official_title>Cesarean Niche Examination by us to Assess Its Integrity and Dehescence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aljazeera Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aljazeera Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The developed uterine scar developing due to cesarean section is usually clinically evaluated
      and visualized by transvaginal sonography (TVS) and saline infusion sonography (SIS) or Gel
      installation sonography (GIS)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In 2015, WHO displayed and reveled a systematic review of the research studies in the
      scientific literature to evaluate and asses the linkage and connection between cesarean
      section rates and maternal
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Actual">January 28, 2020</completion_date>
  <primary_completion_date type="Actual">January 25, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The number of women who will have dehesent scar</measure>
    <time_frame>within a week</time_frame>
    <description>transvaginal us showing lower segment with assessing scar</description>
  </primary_outcome>
  <enrollment type="Actual">110</enrollment>
  <condition>Cesarean Section; Dehiscence</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>transvaginal us with 2D and 3D SHG</intervention_name>
    <description>transvaginal us is made to all women with SHG</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        In 2015, WHO displayed and reveled a systematic review of the research studies in the
        scientific literature to evaluate and asses the linkage and connection between cesarean
        section rates and maternal,
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - women with secondary infertility

        Exclusion Criteria:

          -  obstructed labor, pregnant women having chronic diseases;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>females with a previous section and has secondary infertility</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Alalfy, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Algezeera hospitaland National Research Centre ,Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Algazeerah and Kasralainy hospital</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Algazeerah</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>August 30, 2019</study_first_submitted>
  <study_first_submitted_qc>August 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2019</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aljazeera Hospital</investigator_affiliation>
    <investigator_full_name>Mahmoud Alalfy</investigator_full_name>
    <investigator_title>Researcher , lecturer ,Obstetrics and Gynecology , National Research Centre</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

